Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence

Low carbohydrate diets have a promising mechanistic rationale in the treatment of cancer with favorable preclinical data. The strongest data suggest synergistic effects of dietary interventions with traditional cancer therapies. Recent prospective clinical trials suggest that low carbohydrate diets...

Descripción completa

Detalles Bibliográficos
Autores principales: Haskins, Christopher, Cohen, Justin, Kotecha, Rupesh, Kaiser, Adeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655114/
https://www.ncbi.nlm.nih.gov/pubmed/34901101
http://dx.doi.org/10.3389/fnut.2021.662952
_version_ 1784612014042120192
author Haskins, Christopher
Cohen, Justin
Kotecha, Rupesh
Kaiser, Adeel
author_facet Haskins, Christopher
Cohen, Justin
Kotecha, Rupesh
Kaiser, Adeel
author_sort Haskins, Christopher
collection PubMed
description Low carbohydrate diets have a promising mechanistic rationale in the treatment of cancer with favorable preclinical data. The strongest data suggest synergistic effects of dietary interventions with traditional cancer therapies. Recent prospective clinical trials suggest that low carbohydrate diets are safely and feasibly added within a busy oncology clinic, with hopeful additive effects in treatment enhancement.
format Online
Article
Text
id pubmed-8655114
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86551142021-12-10 Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence Haskins, Christopher Cohen, Justin Kotecha, Rupesh Kaiser, Adeel Front Nutr Nutrition Low carbohydrate diets have a promising mechanistic rationale in the treatment of cancer with favorable preclinical data. The strongest data suggest synergistic effects of dietary interventions with traditional cancer therapies. Recent prospective clinical trials suggest that low carbohydrate diets are safely and feasibly added within a busy oncology clinic, with hopeful additive effects in treatment enhancement. Frontiers Media S.A. 2021-11-25 /pmc/articles/PMC8655114/ /pubmed/34901101 http://dx.doi.org/10.3389/fnut.2021.662952 Text en Copyright © 2021 Haskins, Cohen, Kotecha and Kaiser. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Haskins, Christopher
Cohen, Justin
Kotecha, Rupesh
Kaiser, Adeel
Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
title Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
title_full Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
title_fullStr Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
title_full_unstemmed Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
title_short Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
title_sort low carbohydrate diets in cancer therapeutics: current evidence
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655114/
https://www.ncbi.nlm.nih.gov/pubmed/34901101
http://dx.doi.org/10.3389/fnut.2021.662952
work_keys_str_mv AT haskinschristopher lowcarbohydratedietsincancertherapeuticscurrentevidence
AT cohenjustin lowcarbohydratedietsincancertherapeuticscurrentevidence
AT kotecharupesh lowcarbohydratedietsincancertherapeuticscurrentevidence
AT kaiseradeel lowcarbohydratedietsincancertherapeuticscurrentevidence

Ejemplares similares